BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 30723784)

  • 1. Alpha-1 Antitrypsin Substitution for Extrapulmonary Conditions in Alpha-1 Antitrypsin Deficient Patients.
    Baranovski BM; Schuster R; Nisim O; Brami I; Lior Y; Lewis EC
    Chronic Obstr Pulm Dis; 2018 Sep; 5(4):267-276. PubMed ID: 30723784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence of emphysema post-lung transplantation in a patient with alpha 1 antitrypsin deficiency (AATD).
    Ataya A
    Respir Med Case Rep; 2020; 31():101309. PubMed ID: 33304809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spectrum of clinical sequelae associated with alpha-1 antitrypsin deficiency.
    Tejwani V; Stoller JK
    Ther Adv Chronic Dis; 2021; 12_suppl():2040622321995691. PubMed ID: 34408829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of complement component 3 is associated with airways disease and pulmonary emphysema in alpha-1 antitrypsin deficiency.
    O'Brien ME; Fee L; Browne N; Carroll TP; Meleady P; Henry M; McQuillan K; Murphy MP; Logan M; McCarthy C; McElvaney OJ; Reeves EP; McElvaney NG
    Thorax; 2020 Apr; 75(4):321-330. PubMed ID: 31959730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term experience in the treatment of α1-antitrypsin deficiency: 25 years of augmentation therapy.
    Teschler H
    Eur Respir Rev; 2015 Mar; 24(135):46-51. PubMed ID: 25726554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-1 antitrypsin augmentation therapy.
    Wewers MD; Crystal RG
    COPD; 2013 Mar; 10 Suppl 1():64-7. PubMed ID: 23527997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Neutrophils in Alpha-1 Antitrypsin Deficiency.
    McCarthy C; Reeves EP; McElvaney NG
    Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S297-304. PubMed ID: 27564664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung and liver transplantation in patients with alpha-1 antitrypsin deficiency.
    Zamora MR; Ataya A
    Ther Adv Chronic Dis; 2021; 12_suppl():20406223211002988. PubMed ID: 34408830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The important role of primary care providers in the detection of alpha-1 antitrypsin deficiency.
    Lascano JE; Campos MA
    Postgrad Med; 2017 Nov; 129(8):889-895. PubMed ID: 28929906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and augmentation therapy for alpha-1 antitrypsin deficiency: current knowledge and future potential.
    Feitosa PH
    Drugs Context; 2023; 12():. PubMed ID: 37521109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using antisense technology to develop a novel therapy for α-1 antitrypsin deficient (AATD) liver disease and to model AATD lung disease.
    Guo S; Booten SL; Watt A; Alvarado L; Freier SM; Teckman JH; McCaleb ML; Monia BP
    Rare Dis; 2014; 2():e28511. PubMed ID: 25054094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha 1 Antitrypsin Therapy in Patients with Alpha 1 Antitrypsin Deficiency: Perspectives from a Registry Study and Practical Considerations for Self-Administration During the COVID-19 Pandemic.
    Herth FJF; Sandhaus RA; Turner AM; Sucena M; Welte T; Greulich T
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2983-2996. PubMed ID: 34754184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-1 Antitrypsin Deficiency and Accelerated Aging: A New Model for an Old Disease?
    Crossley D; Stockley R; Sapey E
    Drugs Aging; 2019 Sep; 36(9):823-840. PubMed ID: 31179525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of augmentation therapy for alpha-1 antitrypsin deficiency.
    Mohanka M; Khemasuwan D; Stoller JK
    Expert Opin Biol Ther; 2012 Jun; 12(6):685-700. PubMed ID: 22500781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and safety of inhaled human α-1 antitrypsin in people with α-1 antitrypsin deficiency-related emphysema.
    Franciosi AN; McCarthy C; McElvaney NG
    Expert Rev Respir Med; 2015 Apr; 9(2):143-51. PubMed ID: 25598013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-1 Antitrypsin Augmentation Inhibits Proteolysis of Neutrophil Membrane Voltage-Gated Proton Channel-1 in Alpha-1 Deficient Individuals.
    Hawkins P; Sya J; Hup NK; Murphy MP; McElvaney NG; Reeves EP
    Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441020
    [No Abstract]   [Full Text] [Related]  

  • 17. Alpha-1 Antitrypsin Therapy Modifies Neutrophil Adhesion in Patients with Obstructive Lung Disease.
    McEnery T; White MM; Gogoi D; Coleman O; Bergin D; Jundi B; Flannery R; Alsaif FAT; Landers SA; Casey M; Dunlea D; Meleady P; McElvaney NG; Reeves EP
    Am J Respir Cell Mol Biol; 2022 Jul; 67(1):76-88. PubMed ID: 35507773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in Alpha-1 Antitrypsin Gene Therapy.
    Lorincz R; Curiel DT
    Am J Respir Cell Mol Biol; 2020 Nov; 63(5):560-570. PubMed ID: 32668173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanding the clinical indications for α(1)-antitrypsin therapy.
    Lewis EC
    Mol Med; 2012 Sep; 18(1):957-70. PubMed ID: 22634722
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.